Author

C. khantwal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. B. Salam· 1 shared A. Gheberemedhin· 1 shared B. Adu-Addai· 1 shared C. Andrews· 1 shared C. Yates· 1 shared D. S. Kantner· 1 shared E. A. Noel· 1 shared G. A. Timblin· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. B. Salam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Coenzyme A governs proinflammatory macrophage metabolism

G. A. Timblin, K. M. Tharp, J. t. Hoeve, D. S. Kantner, I. Baydemir, E. A. Noel, C. Khantwal, P. K. Singh, J. N. Farahzad, J. Dominguez-Andres, R. E. Vance, N. W. Snyder, V. M. Weaver

This study shows that exogenous CoA enhances TLR-driven proinflammatory and antimicrobial responses in macrophages by promoting oxidative metabolism and histone acetylation.

bioRxiv · Aug 30, 2022 · PreprintImmunology

A Novel CD206 Targeting Peptide Inhibits Bleomycin Induced Pulmonary Fibrosis in Mice

A. Gheberemedhin, A. B. Salam, B. Adu-Addai, S. Noonan, R. Stratton, M. S. U. Ahmed, C. khantwal, G. Martin, L. Huixian, C. Andrews, K. Balasubramanyam, R. Udo, L. Henry, J. Jaynes, C. Yates

This study shows that RP-832c, a CD206-targeting peptide, reduces bleomycin-induced pulmonary fibrosis in mice by decreasing fibrosis markers and inflammatory cytokines, with efficacy comparable to Pirfenidone and better than Nintedanib.

bioRxiv · Jul 27, 2020 · PreprintPathology